India's coronavirus vaccine shows to generate a robust immune response in 1st phase clinical trials

▴ India's coronavirus vaccine shows to generate a robust immune response in 1st phase clinical trials
ICMR has informed that the vaccine can be stored at 2 and 8-degree centigrade temperatures which also makes it compatible with the National Immunization plan

India's indigenous coronavirus vaccine, Covaxin, has shown to generate a robust immune response in its first phase clinical trials.

A detailed immunogenicity response of the first phase trials of the vaccine has been declared by the manufacturers. Covaxin, jointly developed by Hyderabad based Bharat Biotech and ICMR has been found to be safe generating no serious adverse effects in people of all dose groups as per the results of the first phase clinical trials. ICMR has informed that the vaccine can be stored at 2 and 8-degree centigrade temperatures which also makes it compatible with the National Immunization plan.

Covaxin is one among the three coronavirus vaccine candidates being considered for emergency use authorisation in India by the Drug regulator. It is currently in its third and last phase of clinical trials with nearly 26 thousand volunteers in the age group of 18 and 55.

The ongoing trend of contraction of India’s total active cases continues. The active caseload of the country stands at 3,32,002. The share of Active Cases in the total Positive Cases has further shrunk to 3.34%.

In the last 24 hours, only 26,382 persons were found to be infected with COVID in India. In the same period, India also registered 33,813 new recoveries ensuring a net decline of 7,818 cases in the Active Caseload.

India has recorded less than 40,000 daily new cases since the last 17 days.

Tags : #BharatBiotech #LatestNewsonCOVIDVaccine17thDec #LatestPharmaNews17thDec #ICMR #IndiaFightsCorona #Unite2FightCorona #ActiveCaseload #NatioanalImmuzationPlan

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-



Trending Now

Actor-Director Sathish Kaushik Died of a Heart Attack at the Age of 66March 09, 2023
Soleus Push-Ups: A Laziest Exercise to Lower Blood Sugar LevelsMarch 09, 2023
World Kidney Day 2023: Be Aware of Kidney DiseasesMarch 09, 2023
Sushmita Sen reveals about suffering from a severe heart attack recently and Addison's disease in 2014March 06, 2023
A significant increase in influenza A H3N2 patients that are accompanied by severe coughing and feverMarch 06, 2023
Is AIDS or HIV curable in Ayurveda?March 03, 2023
Artificial Sweetener Erythritol Raises the Possibility of Heart Attack.March 01, 2023
Difference between HIV and AIDS - When to give antiretroviral therapy?March 01, 2023
Zero Discrimination Day: Let's Raise the Voice Against DiscriminationMarch 01, 2023
International Women’s Day 2023 – Embrace EquityFebruary 28, 2023
Brain Tumors - Types, Symptoms and Risk FactorsFebruary 28, 2023
World Rare Disease Day: End Stigma Against Rare Diseases.February 28, 2023
National Science Day 2023 - Global Science for Global WellbeingFebruary 28, 2023
Eating disorders - Types and their complicationsFebruary 27, 2023
The condition that took away the life of Malayalam filmmaker, Joseph ManuFebruary 27, 2023
World NGO Day 2023 - We make a living by what we get, but we make a life by what we giveFebruary 27, 2023
Functions and Problems of SerotoninFebruary 25, 2023
Arthritis management – Tips to manage arthritis effectivelyFebruary 25, 2023
Apple has undertaken a project of no-prick blood sugar monitoring feature for its watch.February 24, 2023
Bird flu – Jharkhand on alert, know its prevention and symptoms in humansFebruary 24, 2023